Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate.
Tse JR, Engler AJ. · 2011
Read Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate. by Tse JR, Engler AJ. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3016411.txt.
Introduction
Tse and Engler grew mesenchymal stem cells on gels with stiffness gradients in a 2011 study, asking whether cells migrate toward stiffer ground before choosing a fate. Real tissues vary in stiffness smoothly, and heart scars create steep local gradients.
On a gentle, body-like gradient the cells crawled uphill toward stiffer regions rather than staying put, over three weeks in culture. There they adopted a more contractile, muscle-like character. Cells still travelling kept a hint of a nerve marker, so their fate was not fully fixed en route. Gradient itself, not just stiffness, steers stem cell behaviour.
Catalog record
| CREATOR | Tse JR, Engler AJ. |
|---|---|
| YEAR | 2011 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Stiffness Gradients Mimicking In Vivo Tissue Variation Regulate Mesenchymal Stem Cell Fate By Justin R Tse, Adam J Engler, Nic D Leipzig Published in: PLoS ONE DOI: 10.1371/journal.pone.0015978 ABSTRACT Abstract Mesenchymal stem cell (MSC) differentiation is regulated in part by tissue stiffness, yet MSCs can often encounter stiffness gradients within tissues caused by pathological, e.g., myocardial infarction ∼8.7±1.5 kPa/mm, or normal tissue variation, e.g., myocardium ∼0.6±0.9 kPa/mm; since migration predominantly occurs through physiological rather than pathological gradients, it is not clear whether MSC differentiate or migrate first. MSCs cultured up to 21 days on a hydrogel containing a physiological gradient of 1.0±0.1 kPa/mm undergo directed migration, or durotaxis, up stiffness gradients rather than remain stationary. Temporal assessment of morphology and differentiation markers indicates that MSCs migrate to stiffer matrix and then differentiate into a more contractile myogenic phenotype. In those cells migrating from soft to stiff regions however, phenotype is not completely determined by the stiff hydrogel as some cells retain expression of a neural marker. These data may indicate that stiffness variation, not just stiffness alone, can be an important regulator of MSC behavior. INTRODUCTION In their niche, cells are presented with an array of complex biophysical and biochemical signals from the surrounding extracellular matrix (ECM) [1], [2], [3]. The Young's modulus, E, often referred to in a biological context simply as elasticity or stiffness, is an intrinsic ECM characteristic that has a profound effect on cell spreading, morphology, and function [4], [5], [6], [7]. In particular, stem cells show lineage-specific differentiation when cultured on substrates matching the stiffness corresponding to native tissue; neural stem cells become either neural or glial lineages depending on matrix elasticity [8], pre-osteoblasts most efficiently form calcified deposits when cultured on optimally stiff substrates [9], and multipotent mesenchymal stem cells (MSCs) [10] become neurogenic, myogenic, and osteogenic when cultured on substrates mimicking neural, muscle, and bone stiffness environments, respectively [11], [12], by regulating their cell tension [11], [13]. However these studies utilize polymer systems that have static parameters while their native counterparts reside in a dynamic environment in which elasticity may change spatially and/or temporally. For example, epicardial stiffness increases approximately 3-fold during development [14] while myocardium post-infarction forms a fibrotic scar that is 3- to 4-fold more stiff than surrounding muscle [15]. Elasticity also varies naturally at interfaces, e.g. hard, calcified bones are connected to soft cartilage [11], [16]. As MSCs egress from bone marrow and hone to these interfaces or migrate through tissue [17], they may encounter such stiffness gradient(s), and it is not clear whether the MSC response to these stimuli is to remain in place and differentiate, as with static materials [11], [12], or migrate in response to the stiffness gradient as with fibroblasts [18]. Several methods have developed in vitro elasticity gradients starting with polymerizing adjacent solutions of differing polymer concentrations to obtain a gradient at the solution interface [18]. More complex methods have employed microfluidic devices [19] or photolithographically-patterned photoactivated initiators [19], [20], [21], [22] to generate monomer and/or crosslinking density gradients. A hallmark of these studies is the observation that most somatic cells, e.g. fibroblasts, endothelial cells, and vascular smooth muscle cells [18], [19], [20], [21], [23], migrate in response to stiffness gradients in a process called “durotaxis,” with specific exceptions for cells originating from highly stratified structures [22]. However gradient strength, i.e. the degree of stiffness change per length, for these studies is typically in a pathological rather than physiological range [15]. A notable exception has shown that somatic cell migration is dependent on gradient strength, though the shallowest gradient – 10 kPa/mm – was still within a pathological range [24]. While some somatic cells may durotax in physiological gradients [20], each mature cell type exhibits lineage specific behavior within a physiologically relevant stiffness range [4], [6], [25]. On the other hand, undifferentiated MSCs lack such a preference and are in fact programmed by these surroundings [11], [12], [13]. Since much of their migration is likely to occur through tissue with physiological rather than pathological gradient(s) before reaching the site in need of regeneration, perhaps a more fundamental question is whether they durotax when presented with a physiological stiffness gradient <1 kPa/mm in the absence of other stimuli, e.g. soluble growth factor gradients which could induce chemotaxis. To better understand the role this potential signal could play in MSC fate, we cultured MSCs on a photopolymerized polyacrylamide (PA) hydrogel of varying stiffness and provide the first evidence that MSCs indeed appear to undergo durotaxis rather than remain stationary. Morphological and lineage marker assessment indicates that MSCs, even within shallow durotactic gradients, migrate to stiffer matrix and then differentiate into a more contractile cell, though this behavior is complicated by some degree of ‘memory’ of the previously soft environment from which they migrated. RESULTS Surface Characterization of Gradient Hydrogels A photomask with a radial grayscale pattern was used to create a crosslinking gradient in a 10% acrylamide/0.3% bis-acrylamide hydrogel via selective activation of the photoinitiator Irgacure 2959 (Fig. 1A [26]). The elastic modulus with respect to distance from the edge to center of the hydrogels was measured by atomic force microscopy (AFM) and found to have a range of 1 to 14 kPa (Fig. 1B). Data was found to have a gradient strength of 1.0±0.1 kPa/mm. Such a gradient is within the physiological range of natural cardiac tissue variations, e.g. 0.6±0.9 kPa/mm, and considerably less than the pathophysiological range of infarct cardiac tissue, e.g. 8.7±1.5 kPa/mm, as previously measured [15]. To permit cell attachment, both gradient and static hydrogels were covalently functionalized with type I collagen using Sulfo-SANPAH, which showed relatively uniform attachment via antibody staining when observed in the XZ cross-section by confocal microscopy (Fig. 1C). Quantitative comparison of fluorescent intensity along the surface of the hydrogel indicated that any intensity variations were not statistically different (p = 0.87). Micron-sized antibody-bound beads were substituted for secondary antibodies to ensure that protein was surface accessible across the stiffness gradient and between static hydrogels of different stiffness or those with similar stiffness but different bulk polymer concentration (Fig. S1). Biochemical assessment of protein concentration (Fig. S1B inset) also demonstrated uniform bulk functionalization. [Figure: Hydrogel fabrication and characterization.(a) The schematic shows (from top to bottom) the 25 mm diameter aminosilanated glass coverslip, the acrylamide/bis-acrylamide solution with dissolved photoinitiator, a chlorosilanated glass slide, patterned photomask, negative photomask, and 254 nm UV light source. (b) AFM-determined elasticity of PA hydrogels was measured by every 1 mm from the center to the edge of the circular hydrogel. The gradient spans 10-fold change in elasticity from 1 to 14 kPa with a gradient strength of 0.96±0.12 kPa/mm. The inset shows a comparison of gradient strength of the hydrogel to those found in infarcted rat myocardium and the natural variations in adjacent, unaffected myocardium [15]. (c) Confocal microscopy images of collagen functionalized PA gradient (top) and static (bottom) hydrogels show collagen localized to the top surface of the hydrogels with roughly uniform distribution regardless of spatial changes in elasticity.] MSCs Durotax to Stiffer Regions of the Gradient Human mesenchymal stem cells (MSCs) were cultured on the collagen I-coated gradient hydrogels to determine whether MSCs will undergo directed migration on hydrogels or will differentiate in